The burden of primary diseases is substantial, demanding advanced therapeutic strategies. Regenerative therapies represent a remarkably exciting avenue, offering the possibility to restore damaged parenchymal tissue and improve clinical outcomes. Currently, research focuses on several techniques, including the introduction of mesenchymal stem cells